Table 2 Haemoglobin parameters in participants inoculated with Pf 3D7 who did not recrudesce, according to drug treatment

ACT-451840 (1)

136

9.33

9

DSM265 (12)

135

(130–141)

10.9

(10.4–12.9)

21

(14–23)

DSM265 + Artefenomel (7)

115

(114–139)

10.6

(6.1–11.6)

21

(20–28)

Ferroquine (8)

129

(118–133)

11.3

(9.3–12.8)

20

(18–21)

Griseofulvin (3)

140

(136–146)

8.5

(6.8–9.3)

11

(4–20)

Cipargamin (4)

139

(133–144)

10.0

(8.0–13.0)

20

(12–23)

M5717 (20)

136

(132–142)

10.6

(8.5–12.9)

10

(6–14)

MMV048 (13)

138

(131–143)

11.4

(8.4–14.2)

9

(8–12)

Mefloquine (22)

127

(120–139)

9.1

(7.9–14.7)

4

(0–9)

Artefenomel (16)

125

(119–139)

8.6

(7.5–9.7)

8

(1–21)

Artefenomel + Piperaquine (21)

132

(127–140)

9.1

(7.0–13.2)

14

(0–27)

Piperaquine (23)

129

(120–140)

10.8

(6.3–13.0)

19

(0–23)

Piperaquine + Primaquine (2)

127–138

4.2–13.0

7–20

SJ733 (10)

136

(130–140)

9.8

(8.3–11.6)

12

(10–20)

ZY-19849 (6)

128

(122–137)

10.9

(5.5–11.6)

7

(3–8)